ABSTRACT In a study designed to show whether purulent bronchial secretions damage the lung reversibly or irreversibly, 18 patients with bronchiectasis underwent lung function tests before and after two weeks' antibiotic treatment to convert their sputum from purulent to mucoid, and 10 of them also after four months' treatment. After two weeks FEVy, forced vital capacity, vital capacity, functional residual capacity, and total lung capacity showed small but statistically significant (though not clinically useful) improvements. In the 10 patients studied after four months only FVC (of the four indices with significant improvements at two weeks in this group) was still higher than before treatment. These results contrast with those of an earlier study, in which large acute changes were found, perhaps because of differences in the patients studied. It is concluded that the absence of major changes in lung function points to physiological abnormality that is largely irreversible in these patients with chronic bronchial sepsis.
Patients with bronchiectasis who usually produce purulent, elatase positive secretions have worse lung function than those who produce mucoid secretions.'
This raised the possibility that the type of secretion could determine the degree of lung damage. Cole and his colleagues,2 however, suggested that major changes in forced expiratory volumes could occur after one week of successful antibiotic treatment. This point was emphasised in a recent leading article in the British Medical Journal3 and suggests that the abnormality previously observed by us could be reversible.
A preliminary study of our own patients suggested that major changes in lung function did not occur after short term antibiotic treatment. 4 Fourteen patients were lifelong non-smokers and four had ceased smoking at least two years earlier. Three had previously undergone lobectomy for the disease.
All were producing purulent secretions and received a two week course of either amoxycillin or, in two cases, intravenous gentamicin, resulting in macroscopic clearance of their secretions, which changed from purulent to mucoid as assessed by SLH. Lung function tests were performed before and at the end of treatment. Ten patients continued treatment for a total of four months, during which time their sputum remained mucoid, and they were retested at the end of the treatment period.
Dynamic lung volumes, FEV,, and forced vital capacity (FVC) were measured with a wedge bellows spirometer (Vitalograph). Values for static lung volumes, vital capacity (VC), residual volume (RV), and total lung capacity (TLC) were obtained during and from the determination of functional residual capacity (FRC), for which the helium dilution method was used. Transfer factor for carbon monoxide (TLCO), and the transfer coefficient (Kco) were determined by the single breath method. All measurements were corrected to BTPS.
Bronchodilator treatment was stopped for at least 12 hours before lung function testing on every occasion and the measurements were performed in the morning at about the same time (to within one hour) by SLH. All patients carried out their usual morning postural drainage routine before attending for tests.
Effect ofshort and long term antibiotic response on lung function in bronchiectasis At the first visit we did a bronchodilator challenge with a f2 agonist delivered from a metered dose inhaler (Rimiterol, 4 x 200 pg).
The significance of any difference after treatment was determined by means of Student's t test for paired data.
Results
Only one patient showed clear reversibility of FEV1 after formal bronchodilator challenge of more than 15%, which represented an actual change of 0-88-104 litres. The remainder showed little or no response, with a mean increase in FEV1 of 4-3% (SD 4-97%).
The average changes in lung function indices over two weeks for the 18 patients are summarised in table 1 . Small but significant increases were seen in FEV1, FVC, VC, FRC, and TLC.
The results for the 10 patients studied over four months are summarised in table 2. Similar changes in FEV1, FVC, FRC, and TLC were seen in this group. By four months, however, only the better than the pretreatment results.
FVC remained Discussion
The present results show that after a two week course of successful antibiotic treatment only small increases (about 5%).were observed for FEV1, FVC, VC, FRC, and TLC. This change could be the effect of reduction in sputum volume, which we have shown to be associated with the response to antibiotics in these patients.5 In support of this is the similarity to the 8% increase in FEV1 reported by Cochrane etal6 after chest physiotherapy in a similar group of patients. Another possibility is a small degree of bronchodilation as a result of antibiotic treatment. This would be consistent with the small increase in FEV1 observed after bronchodilator challenge (see "Results"). All patients were assessed after f2 agonist treatment had been withdrawn and hence the antibiotic effect is not due to this other treatment.
The changes we observed in lung function are at 800 variance with the acute changes found by Cole et al2 after antibiotic treatment. These workers found increases in FEV1, FVC and peak flow of 50%, 32%, and 36% respectively in a group of 17 patients after seven days of treatment. These increases were even more dramatic when their group was further divided and subjective responders were examined; increases of 91%, 50%, and 64% were seen for the same indices of lung function. No information was provided by these workers on the degree of formal bronchodilator reversibility. 
